Clinical Trial Update: Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of clarithromycin to prevent bronchopulmonary dysplasia in premature infants. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Chronic Lung Disease | Phase 4 | Status: COMPLETED